SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel Detroit Metropolitan Area, Michigan, USA, May-June 2020

被引:53
作者
Akinbami, Lara J. [1 ,2 ]
Vuong, Nga [3 ]
Petersen, Lyle R. [3 ]
Sami, Samira [4 ,5 ]
Patel, Anita [4 ]
Lukacs, Susan L. [1 ,2 ]
Mackey, Lisa [3 ]
Grohskopf, Lisa A. [2 ,4 ]
Shehu, Amy [6 ]
Atas, Jenny [6 ]
机构
[1] Ctr Dis Control & Prevent, 3311 Toledo Rd,Mailstop P08, Hyattsville, MD 20782 USA
[2] US PHS, Rockville, MD USA
[3] Ctr Dis Control & Prevent, Ft Collins, CO USA
[4] Ctr Dis Control & Prevent, Atlanta, GA USA
[5] Epidem Intelligence Serv, Atlanta, GA USA
[6] Reg 2 South Healthcare Coalit, Detroit, MI USA
关键词
D O I
10.3201/eid2612.203764
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To estimate seroprevalence of severe acute respiratory syndrome 2 (SARS-CoV-2) among healthcare, first response, and public safety personnel, antibody testing was conducted in emergency medical service agencies and 27 hospitals in the Detroit, Michigan, USA, metropolitan area during May-June 2020. Of 16,403 participants, 6.9% had SARS-CoV-2 antibodies. In adjusted analyses, seropositivity was associated with exposure to SARS-CoV-2-positive household members (adjusted odds ratio [aOR] 6.18, 95% CI 4.81-7.93) and working within 15 km of Detroit (aOR 5.60, 95% CI 3.98-7.89). Nurse assistants (aOR 1.88, 95% CI 1.24-2.83) and nurses (aOR 1.52, 95% CI 1.18-1.95) had higher likelihood of seropositivity than physicians. Working in a hospital emergency department increased the likelihood of seropositivity (aOR 1.16, 95% CI 1.002-1.35). Consistently using N95 respirators (aOR 0.83, 95% CI 0.72-0.95) and surgical facemasks (aOR 0.86, 95% CI 0.75-0.98) decreased the likelihood of seropositivity.Y
引用
收藏
页码:2863 / 2871
页数:9
相关论文
共 23 条
  • [1] Changes to physician and nurse time burdens when caring for patients under contact precautions
    Barker, Anna K.
    Codella, James
    Ewers, Tola
    Dundon, Adam
    Alago, Oguzhan
    Safdar, Nasia
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2017, 45 (05) : 542 - 543
  • [2] Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak
    Brandstetter, Susanne
    Roth, Samra
    Harner, Susanne
    Buntrock-Doepke, Heike
    Toncheva, Antoaneta A.
    Borchers, Natascha
    Gruber, Rudolf
    Ambrosch, Andreas
    Kabesch, Michael
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 (07) : 841 - 847
  • [3] Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity
    Clapham, Hannah
    Hay, James
    Routledge, Isobel
    Takahashi, Saki
    Choisy, Marc
    Cummings, Derek
    Grenfell, Bryan
    Metcalf, C. Jessica E.
    Mina, Michael
    Rodriguez-Barraquer, Isabel
    Salje, Henrik
    Tam, Clarence C.
    [J]. EMERGING INFECTIOUS DISEASES, 2020, 26 (09) : 1978 - 1986
  • [4] FDA (U.S. Food and Drug Administration), 2020, EUA AUTH SER TEST PE
  • [5] Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
    Feehan, Amy K.
    Fort, Daniel
    Garcia-Diaz, Julia
    Price-Haywood, Eboni G.
    Velasco, Cruz
    Sapp, Eric
    Pevey, Dawn
    Seoane, Leonardo
    [J]. EMERGING INFECTIOUS DISEASES, 2020, 26 (11) : 2765 - 2768
  • [6] Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
    Havers, Fiona P.
    Reed, Carrie
    Lim, Travis
    Montgomery, Joel M.
    Klena, John D.
    Hall, Aron J.
    Fry, Alicia M.
    Cannon, Deborah L.
    Chiang, Cheng-Feng
    Gibbons, Aridth
    Krapiunaya, Inna
    Morales-Betoulle, Maria
    Roguski, Katherine
    Rasheed, Mohammad Ata Ur
    Freeman, Brandi
    Lester, Sandra
    Mills, Lisa
    Carroll, Darin S.
    Owen, S. Michele
    Johnson, Jeffrey A.
    Semenova, Vera
    Blackmore, Carina
    Blog, Debra
    Chai, Shua J.
    Dunn, Angela
    Hand, Julie
    Jain, Seema
    Lindquist, Scott
    Lynfield, Ruth
    Pritchard, Scott
    Sokol, Theresa
    Sosa, Lynn
    Turabelidze, George
    Watkins, Sharon M.
    Wiesman, John
    Williams, Randall W.
    Yendell, Stephanie
    Schiffer, Jarad
    Thornburg, Natalie J.
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (12) : 1576 - 1586
  • [7] Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437
  • [8] Prevalence of Coronavirus Disease 2019 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington
    Mani, Nandita S.
    Budak, Jehan Z.
    Lan, Kristine F.
    Bryson-Cahn, Chloe
    Zelikoff, Allison
    Barker, Gwendolyn E. C.
    Grant, Carolyn W.
    Hart, Kristi
    Barbee, Carrie J.
    Sandoval, Marissa D.
    Dostal, Christine L.
    Corcorran, Maria
    Ungerleider, Hal M.
    Gates, Jeff O.
    Olin, Svaya, V
    Bryan, Andrew
    Hoffman, Noah G.
    Marquis, Sara R.
    Harvey, Michelle L.
    Nasenbeny, Keri
    Mertens, Kathleen
    Chew, Lisa D.
    Greninger, Alexander L.
    Jerome, Keith R.
    Pottinger, Paul S.
    Dellit, Timothy H.
    Liu, Catherine
    Pergam, Steven A.
    Neme, Santiago
    Lynch, John B.
    Kim, H. Nina
    Cohen, Seth A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2702 - 2707
  • [9] Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5-18, 2020-22 States, February-June 2020
    Moore, Jazmyn T.
    Ricaldi, Jessica N.
    Rose, Charles E.
    Fuld, Jennifer
    Parise, Monica
    Kang, Gloria J.
    Driscoll, Anne K.
    Norris, Tina
    Wilson, Nana
    Rainisch, Gabriel
    Valverde, Eduardo
    Beresovsky, Vladislav
    Brune, Christine Agnew
    Oussayef, Nadia L.
    Rose, Dale A.
    Adams, Laura E.
    Awel, Sindoos
    Villanueva, Julie
    Meaney-Delman, Dana
    Honein, Margaret A.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (33): : 1122 - 1126
  • [10] National Institute for Occupational Safety and Health, NIOSH IND OCC COMP C